您的位置: 首页 > 农业专利 > 详情页

BISPECIFIC ANTIBODY-MEDIATED CANCER THERAPY WITH CYTOKINE-INDUCED KILLER CELL
专利权人:
Ltd.;Wuhan YZY Biopharma Co.
发明人:
Pengfei Zhou,Tao Wang,Liu Hu,Mi Huang,Lijuan Fang,Yang Liu
申请号:
US15327973
公开号:
US20180312606A1
申请日:
2014.07.21
申请国别(地区):
US
年份:
2018
代理人:
摘要:
Provided are compositions comprising a MSBODY and a cytotoxic immune cell (e.g., Cytokine-induced killer cell) to form Armed Activated CIK cells (ACCs), wherein the MSBODY comprising a first antigen binding moiety that has specificity for a tumor antigen, and a second antigen binding moiety that binds to the cell. Provided are also methods preparing a composition comprising a MSBODY and a cytotoxic immune cell, and methods for treating patients with CIK cells armed with bispecific antibodies.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充